MUTANT MOUSE RESOURCE AND RESEARCH CENTER: ANIMAL EMBRYONIC STEM CELLS

突变小鼠资源与研究中心：动物胚胎干细胞

• 批准号: 7621964
• 负责人: JOHN K. CRITSER
• 金额: $ 6.52万
• 依托单位: UNIVERSITY OF MISSOURI-COLUMBIA
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2008-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7621964
• 关键词: Animals; Archives; Arts; Assisted Reproductive Technology; Biomedical Research; Biosensor; Cells; Communities; Computer Retrieval of Information on Scientific Projects Database; Congenic Strain; Cryopreservation; Development; Disease; Embryo; Funding; Genetic; Genetically Engineered Mouse; Goals; Grant; Growth; Health; Human; Injection of therapeutic agent; Institution; Intracytoplasmic Sperm Injections; Medical Surveillance; Methodology; Missouri; Modeling; Mus; Mutant Strains Mice; Numbers; Operative Surgical Procedures; Ovarian Tissue; Pathogen detection; Policies; Research; Research Personnel; Research Project Grants; Resources; Services; Source; Speed; Technology; Tissue Transplantation; United States National Institutes of Health; base; cost; embryonic stem cell; improved; new technology; nuclear transfer; repository

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. DESCRIPTION (provided by applicant): The importance of genetically-engineered mice (GEM) as models of human health and disease has been demonstrated unequivocally. Because of the importance of GEM in biomedical research, the numbers of GEM lines have grown exponentially over the last five years; this astronomical growth is predicted to continue. Recognizing the scientific importance of sharing mice among investigators, the NIH developed a mouse sharing policy which states that mouse lines generated with the aid of NIH funding must be distributed and shared with the scientific community. To accomplish this goal, the NIH funded the establishment of four regional Mutant Mouse Resource and Research Centers (MMRRCs) in 1999 and 2000. This application is a competitive renewal for the Missouri/Harlan (M/H) MMRRC. Specific Aims of the proposal are: (1) To improve the efficiencies of the MMRRC service functions while continuing to provide the scientific community with a mutant mouse repository and distribution center of the highest quality. To accomplish this, we will employ state-of-the-art cryopreservation and reanimation (reestablishment of lines after cryopreservation) technologies, such as intracytoplasmic sperm injection (ICSI), nuclear transfer (NT) ovarian tissue (OT) transplantation (OTT) and injection of NT derived embryonic stem cells (ntES cells) into tetraploid embryos (ntES/4N). Using these approaches we will be able to more efficiently import, cryopreserve and reanimate lines at a cost approximately 10% of current, traditional embryo cryopreservation based approaches. (2) To conduct research aimed at increasing the value of the MMRRC. Research will include projects aimed at improving assisted reproductive technologies (ARTs) used for reanimation of mouse lines, development of biosensors for detection of pathogens and health surveillance of mutant mouse colonies, and development of new genetic and ARTs that will revolutionize the speed and efficiency with which congenic strains of mice are made. The proposed approach to the operation of the M/H MMRRC represents a new paradigm for mouse repositories. Recognizing the continued exponential growth of GEM, a new paradigm is mandatory; existing mouse resource centers simply cannot archive all of the important mouse lines using traditional methodology. Furthermore, the proposed research projects will result in even greater efficiencies for the MMRRC and the development of new technologies useful to the entire scientific community.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 描述（由申请人提供）： 基因工程小鼠（GEM）作为人类健康和疾病模型的重要性已得到明确证明。由于 GEM 在生物医学研究中的重要性，GEM 系的数量在过去五年中呈指数级增长；预计这种天文数字的增长将持续下去。认识到研究人员之间共享小鼠的科学重要性，NIH 制定了小鼠共享政策，规定在 NIH 资助下产生的小鼠品系必须与科学界分发和共享。为了实现这一目标，NIH 于 1999 年和 2000 年资助建立了四个区域突变小鼠资源和研究中心 (MMRRC)。此申请是密苏里州/哈兰 (M/H) MMRRC 的竞争性更新。该提案的具体目标是： (1) 提高 MMRRC 服务职能的效率，同时继续为科学界提供最高质量的突变小鼠储存库和配送中心。为了实现这一目标，我们将采用最先进的冷冻保存和复活（冷冻保存后重建细胞系）技术，例如胞浆内单精子注射（ICSI）、核移植（NT）卵巢组织（OT）移植（OTT）以及将NT衍生的胚胎干细胞（ntES细胞）注射到四倍体胚胎（ntES/4N）中。使用这些方法，我们将能够更有效地导入、冷冻保存和复活细胞系，其成本约为当前传统胚胎冷冻保存方法的 10%。 (2) 开展旨在提高 MMRRC 价值的研究。研究将包括旨在改进用于小鼠系复活的辅助生殖技术（ART）的项目，开发用于检测病原体和突变小鼠群体健康监测的生物传感器，以及开发新的遗传和ART，这将彻底改变小鼠同源品系的生产速度和效率。所提出的 M/H MMRRC 操作方法代表了小鼠存储库的新范例。认识到创业板持续呈指数级增长，新的范式势在必行；现有的小鼠资源中心根本无法使用传统方法归档所有重要的小鼠品系。此外，拟议的研究项目将提高 MMRRC 的效率，并开发对整个科学界有用的新技术。